Singapore, Oct. 1 -- AbbVie hasannounced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than$10 billionof capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.
This investment will further expand AbbVie's domestic biologics manufacturing capacity to meet increased global demand and support U.S. production of current and next-generation oncology and immunology medicines. It will include construction of additional biologics manu...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.